XML 13 R4.htm IDEA: XBRL DOCUMENT v3.21.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Statement [Abstract]    
Revenues $ 208
Research and development expenses (Note 11) 1,532 1,606
Selling and Marketing (Note 12) 415 573
General and administrative expenses (Note 13) 1,185 1,535
Total operating expenses 3,132 3,714
Operating loss 3,132 3,506
Other Income 338
Financing income (expense), net 98 (10)
Loss for the period 2,696 3,516
Other comprehensive income:    
Foreign currency translation adjustment (109) (40)
Comprehensive Loss for the period $ 2,805 $ 3,556
Loss per share (Basic) (Note 15) $ (0.02) $ (0.02)
Loss per share (Diluted) (Note 15) $ (0.02) $ (0.02)
Common shares used in computing Basic and Diluted Loss per share (Note 15) 196,029,360 154,929,064